Vitamin B12
Also called: cobalamin, cyanocobalamin, methylcobalamin, adenosylcobalamin, hydroxocobalamin
A water-soluble vitamin containing cobalt, so its compounds are called cobalamins; it is required for the development, myelination and function of the central nervous system. It occurs naturally in animal foods (fish, meat, poultry, eggs, dairy) and is added to fortified cereals and nutritional yeast.
- Category
- Vitamin
- Forms
- Cyanocobalamin (most common); methylcobalamin, adenosylcobalamin, hydroxocobalamin
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2026 Cochrane review of oral vitamin B12 in children under 12 included 16 RCTs (4,083 children); for blood B12 concentration it pooled 7 trials (705 children) of B12 alone versus placebo. Some included trials gave B12 with other micronutrients. [2]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMuscles and exercise1 topic
XBrain, mood and sleep1 topic
XHeart and blood vessels1 topic
XCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Cardiovascular disease | X | A Cochrane review of 15 studies (71,422 participants) found B12 alone or with other B vitamins did not reduce heart attacks or death rates; B-PROOF follow-up (1,298 participants) found no effect. [1] |
| Cognitive function and dementia | X | A Cochrane review of 14 studies (27,882 participants) found little to no effect on global cognition for up to 5 years; a 2,919-adult RCT (500 mcg B12 plus folic acid, 2 years) found no difference. [1] |
| Cancer | X | A meta-analysis of 18 RCTs (74,498 individuals; 20–2,000 mcg/day for 2–7.3 years) found little or no effect on cancer incidence. [1] |
| Energy and athletic performance | C | ODS states that B12 supplementation appears to have no beneficial effect on performance in the absence of a nutritional deficit; no trial details are given. [1] |
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- RDA, adults 19+: men 2.4 mcg; women 2.4 mcg; pregnancy 2.6 mcg; lactation 2.8 mcg. [1]
- Trials used 20–2,000 mcg/day (cancer meta-analysis) and 500 mcg/day with 400 mcg folic acid (B-PROOF and the 2,919-adult cognition trial). [1]
Upper limits
- No UL: vitamin B12 does not have a tolerable upper intake level because it is generally considered safe, even at high doses. [1]
Safety and side effects
- Liver (NIH LiverTox)Score EABCDEA: well known causeE: unlikely cause
LiverTox likelihood score E (unlikely cause of liver injury), Vitamin B chapter updated 2021-05-27: vitamin B12 therapy has not been linked to ALT …
Details and sources - Pregnancy and breastfeedingRDA 2.6 mcg/day in pregnancy and 2.8 mcg/day in lactation; deficiency in pregnant and breastfeeding women might cause neural tube defects, …
1 statement in the profile.
Details and sources - Interactions with medicines2 listed
Proton pump inhibitors and H2 blockers; Metformin
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications15 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Groups at risk of inadequacy: older adults with atrophic gastritis (8% to 9% of adults age 65+), people with pernicious anemia, people who have had gastrointestinal surgery such as weight-loss surgery, vegans and some vegetarians, and exclusively breastfed infants of mothers who eat no animal products. [1]
- Deficiency signs include megaloblastic anemia, fatigue, glossitis, numbness and tingling in the hands and feet, and dementia. [1]
Interactions
| With | What happens |
|---|---|
| Proton pump inhibitors (omeprazole, lansoprazole) | Can interfere with B12 absorption from food by slowing release of gastric acid. [1] |
| H2 receptor antagonists (cimetidine, ranitidine) | Can interfere with B12 absorption from food by slowing release of gastric acid. [1] |
| Metformin | Might reduce B12 absorption and significantly reduce serum B12 concentrations. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Absorption of oral B12 is about 50% at doses below 1–2 mcg but only about 2% at 500 mcg and 1.3% at 1,000 mcg. [1]
Regulatory status
- US: available in dietary supplements and fortified foods. The FDA Daily Value is 2.4 mcg for adults and children age 4 years and older. [1]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Cobalamins: cyanocobalamin (most common in supplements), methylcobalamin, adenosylcobalamin and hydroxocobalamin Cobalamins (cobalt-containing compounds) [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 15 entries naming vitamin B12 or cyanocobalamin (most as part of multi-ingredient products) (earliest NDI 491 submitted 2007-12-03; most recent NDI 868 submitted 2015-04-20). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score E (unlikely cause of liver injury), Vitamin B chapter updated 2021-05-27: vitamin B12 therapy has not been linked to ALT elevations or to clinically apparent acute liver injury. [P5]
Interactions with medicines
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each component that is a dietary ingredient — Required by 21 CFR 111.75(a)(1)(i) for every dietary-ingredient component; an exemption may be requested by petition under 21 CFR 10.30. [P6]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- Absorption from supplements is about 50% at doses below 1–2 mcg, falling to about 2% at 500 mcg and 1.3% at 1,000 mcg; no evidence shows that absorption differs by supplement form, and supplement bioavailability is about 50% higher than from food. [P1]
- In 10 adults (mean age 81), a 1,000 mcg intranasal dose had 2% bioavailability, similar to oral dosing; evidence suggests no difference in efficacy between oral and sublingual forms. [P1]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- RDA 2.6 mcg/day in pregnancy and 2.8 mcg/day in lactation; deficiency in pregnant and breastfeeding women might cause neural tube defects, developmental delays, failure to thrive and anemia in offspring. No UL was set because of low potential for toxicity. [P1]
Sources for this profile
- NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals (updated March 26, 2024), 2024-03-26. ods.od.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. Agents Classified by the IARC Monographs: List of Classifications (accessed 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (accessed 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Vitamin B (Last Update: 2021-05-27), 2021-05-27. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
Sources
- NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals (updated March 26, 2024), 2024-03-26. ods.od.nih.gov
- Larvie DY, et al. Vitamin B12 supplementation for growth, development, and cognition in children. Cochrane Database Syst Rev 2026;6(6):CD015264 (PMID 42227307), 2026-06-02. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in vitamin: Benfotiamine · Biotin · Folate (folic acid) · Methylfolate (L-5-MTHF) · Niacin (vitamin B3) · Nicotinamide riboside · Pantothenic acid (vitamin B5) · Riboflavin (vitamin B2) · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.